# Retatrutide in type 2 diabetes: appetite and eating habits

Source: https://pepvault.app/research/retatrutide-kanu-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Retatrutide](https://pepvault.app/research#retatrutide)

Randomized trial · people

# Retatrutide: less hunger and overeating vs placebo at higher doses

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In adults with type 2 diabetes, the higher retatrutide doses in this trial went along with less reported hunger and overeating, and people who reported these changes tended to lose more weight.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 275
- **Published:** 2025
- **Journal:** Diabetes Obes Metab

## What they tested

The team wanted to know whether retatrutide changes self-reported appetite and eating behavior in adults with type 2 diabetes more than placebo or dulaglutide, and whether those changes track with weight loss.

## How the study was done

This was a planned exploratory look at a randomized, placebo-controlled phase 2 trial in 275 adults with type 2 diabetes. Each week for up to 36 weeks, people received one of four retatrutide doses (from 0.5 mg up to 12 mg), dulaglutide at 1.5 mg, or placebo (a dummy treatment), and they filled in two questionnaires on appetite and eating habits.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 24, people in the retatrutide 4 mg and higher arms reported bigger drops in overall appetite, hunger and how much food they expected to eat than the placebo group (all p <0.05). The 8 and 12 mg arms showed greater improvement than placebo in perceived hunger and disinhibition (the tendency to overeat) at both weeks 24 and 36. Dietary restraint, meaning conscious efforts to limit eating, rose more than with placebo only in the 12 mg arm at week 36. At week 36, less perceived hunger, less disinhibition and more dietary restraint each went along with more weight loss (r = 0.28, r = 0.36 and r = 0.31).

## What it doesn’t show

These were exploratory questionnaire results based on what participants reported themselves, and the links to weight loss came from post hoc correlations, which show an association, not cause. Differences between retatrutide and dulaglutide were less consistent than those against placebo.

## The paper

Kanu et al. Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study. Diabetes Obes Metab. 2025.

- [PubMed (PMID 40916752)](https://pubmed.ncbi.nlm.nih.gov/40916752/)
- [The paper (DOI 10.1111/dom.70097)](https://doi.org/10.1111/dom.70097)

## The compound

- [Retatrutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Retatrutide

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026) Meta-analysis · people · 2026
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: HbA1c down up to 1.94% in TRANSCEND-T2D-1](https://pepvault.app/research/retatrutide-transcend-t2d-1-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: systolic blood pressure down 6.79 mmHg in meta-analysis](https://pepvault.app/research/retatrutide-simental-mendia-2026)
- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [All 16 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

## The library

- [Retatrutide](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
